{{Rsnum
|rsid=7584330
|Chromosome=2
|position=237478585
|Orientation=plus
|GMAF=0.3627
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 34.5 | 8.8
| HCB | 51.5 | 41.9 | 6.6
| JPT | 65.5 | 27.4 | 7.1
| YRI | 5.4 | 32.7 | 61.9
| ASW | 10.5 | 42.1 | 47.4
| CHB | 51.5 | 41.9 | 6.6
| CHD | 60.6 | 32.1 | 7.3
| GIH | 42.6 | 39.6 | 17.8
| LWK | 2.7 | 30.9 | 66.4
| MEX | 55.2 | 39.7 | 5.2
| MKK | 8.3 | 41.7 | 50.0
| TSI | 66.7 | 27.5 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21743467
|Trait=None
|Title=Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.
|RiskAllele=C
|Pval=3E-9
|OR=1.0600
|ORtxt=[1.02-1.09]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}